Combining Molecular Dynamics and Machine Learning to Predict Drug Resistance Causing Variants of BRAF in Colorectal Cancer.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: REST2 molecular-dynamics trajectories and a random-forest classifier relate BRAF variant conformational features to predicted dabrafenib/vemurafenib resistance in colorectal-cancer models; this is a computational variant hypothesis without direct drug-response experiments in this study.
Technology: REST2 molecular-dynamics trajectories and a random-forest classifier relate BRAF variant conformational features to predicted dabrafenib/vemurafenib resistance in colorectal-cancer models; this is a computational variant hypothesis without direct drug-response experiments in this study.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- REST2 molecular-dynamics trajectories and a random-forest classifier relate BRAF variant conformational features to predicted dabrafenib/vemurafenib resistance in colorectal-cancer models; this is a computational variant hypothesis without direct drug-response experiments in this study.
- Limitation / still unknown
- REST2 molecular-dynamics trajectories and a random-forest classifier relate BRAF variant conformational features to predicted dabrafenib/vemurafenib resistance in colorectal-cancer models; this is a computational variant hypothesis without direct drug-response experiments in this study. Primary Methods/Results establish the cohort or experiment, comparison and stated validation limits.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://mdpi-res.com/d_attachment/molecules/molecules-30-03556/article_deploy/molecules-30-03556.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.